Latest News & Features
Europe
The Court of Appeal for England and Wales has upheld the Patent Court’s decision that Teva Pharmaceutical Industries’ UK patent 762,888, relating to the multiple sclerosis drug Copaxone, is valid. 1 August 2013
article
A US court has ruled that an Israeli company’s patent for a multiple sclerosis (MS) drug is invalid, paving the way for rivals to market a generic version. 30 July 2013
Americas
A US court has upheld a decision ruling that a continuation patent filed by a bio-tech company is invalid. 26 July 2013
Americas
The chair of the FTC has said it will continue to challenge pay-for-delay court settlements in the pharmaceutical industry and has hailed a Supreme Court ruling as a victory for consumers. 25 July 2013
Americas
A white paper suggests that patent case settlements between originator pharmaceutical companies and their generic competitors may be beneficial to drug consumers. 25 July 2013
Americas
The chief legal officer at the United States Patent and Trademark Office has announced he will be leaving. 24 July 2013
Americas
Senator Patrick Leahy has urged the US National Institutes of Health to force Myriad Genetics to license its patents directed to tests for breast and ovarian cancer. 19 July 2013
Biotechnology
On July 15, French pharmaceutical company Ipsen announced it has closed the acquisition of life sciences company and research partner Syntaxin. 18 July 2013
Americas
Biotechnology company Genmab A/S announced on July 15 that the US Court of Appeals for the Federal Circuit has refused a request to rehear a case related to its Arzerra product. 17 July 2013
Americas
Pharmaceutical company Glenmark Generics has confirmed that it has filed ANDAs with the US FDA to market generic versions of epilepsy drug Vimpat. 16 July 2013